Daniel Blair, PhD, PhD

Programmed cell death can affect immune response to diseases such as cancer. Learn how caspase-8 chooses cell death and how that decision can be stopped.

NIH seminar elucidates new guidelines for grant-funded research as well as allocation of monies to more labs.

These inherited gene variations may help explain why the risk of relapse for children with acute lymphoblastic leukemia varies by race.

Find out how a newly discovered protein can give your body’s doomed cells a second chance at life.

Research shows possible path to restoring critical regions of the brain involved with hearing loss by limiting a neuromodulator in the auditory thalamus.

Medulloblastoma may soon be treated by a microirradiator - a machine the size of two refrigerators that beams radiation down to half the width of a credit card.

Read how researchers have found a path to control coenzyme A and possibly prevent a devastating neurodegenerative disease.

Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.

Effective leukemia treatment is one thing – making sure it’s optimized with minimal implications is another. Read research juggles both to help patients.

Improving understanding of drugs and how the body reacts to them - - Read how science is improving understanding of genes and medication.